Pharmadrug Inc. (CNSX: PHRX)
Health Care · Pharmaceuticals · CA
CA$0.01
-50.00% today · -50.0% 1Y
Pharmadrug Inc. (CNSX: PHRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $471.92K and employs 9 people.
Over the last twelve months the share price has lost 50.0%, trading between 0.01 and 0.03.
Tweenvest scores Pharmadrug Inc. across four factors: quality 17/100, value 70/100. Its strongest factor is value.
PHRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $471.92K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- CA$0.03
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 134.21M
- Employees
- 9
- Next earnings
- —
About Pharmadrug Inc.
Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to the research, development, and market introduction of controlled substances and natural therapeutics, such as psychedelics, cannabis, and other approved compounds derived from nature. The company also manages the import and supply of medical cannabis to pharmacies across Germany and the broader European Union. Additionally, it operates Super Smart, an entity focused on advancing the application of functional and psilocybin mushrooms, and engages in studies to reformulate established natural medicines. Pharmadrug maintains key research collaborations, including an agreement with the University of Michigan to explore the potential role of N, N-dimethyltryptamine (DMT) in various states of consciousness. It has also partnered with the Southwest Research Institute for the manufacturing of cepharanthine and entered into a clinical trial agreement with Johns Hopkins University to compare the acute and enduring psychological and neural effects of DMT against another potent active molecule. The company adopted its current name in October 2019, having previously operated as Aura Health Inc.
- ISIN
- CA71716W2040
- Founded
- 2011
- Listed since
- Jan 31, 2012
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lumiera Health Inc.TSXV: NHP.H | $621.96K | CA$— | — |
| Decipher Labs LimitedBSE: 524752 | $614.68K | Rs5.89 | -1.83% |
| Sybleu Inc.OTCPK: SYBE | $583.74K | $— | — |
| Aequus Pharmaceuticals Inc.TSXV: AQS | $478.54K | CA$— | 0.00% |
| Tikun Olam-Cannbit Pharmaceuticals LtdTASE: TKUN-M | $462.32K | ₪834.00 | — |
| EGF Theramed Health Corp.CNSX: TMED.X | $458.67K | CA$— | — |
| Fabino Enterprises LimitedBSE: 543444 | $453.32K | Rs— | — |
| RAMM Pharma Corp.CNSX: RAMM | $419.20K | CA$0.01 | -50.00% |
Figures last refreshed Oct 11, 2026.